Clinical Trial 55457

Webster, TX 77598


The SPECTREM Study is researching an investigational medication for people with plaque psoriasis. Psoriasis can impact your quality of life, particularly when it affects sensitive or visible areas like the scalp, face, body folds or genital region. The SPECTREM clinical research study is evaluating how well an investigational medication works for people with psoriasis in these parts of the body.

The SPECTREM Study is open to people of all gender identities, as well as all ethnic and racial backgrounds. By including a diverse population in this clinical research study, we may determine whether potential future treatments could be safe and work for as many people with plaque psoriasis as possible.

Qualified Participants Must:

• You are 18 years or older
• You have been diagnosed with or think you may have plaque psoriasis
• Your psoriasis covers no more than 15% (about 15 handprints) of your body
• Your psoriasis affects at least one of the following areas: scalp, face, body folds or genital region and additionally one other area of your body

Qualified Participants May Receive:

If you are interested, additional eligibility criteria will be assessed by the study doctor or staff to confirm whether you are able to participate. Qualified persons will receive study-required medical care and the investigational medication or placebo at no cost.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.